Literature DB >> 24469593

mTORC1 inhibition in the nucleus accumbens 'protects' against the expression of drug seeking and 'relapse' and is associated with reductions in GluA1 AMPAR and CAMKIIα levels.

Morgan H James1, Rikki K Quinn1, Lin Kooi Ong1, Emily M Levi1, Janine L Charnley1, Doug W Smith1, Phillip W Dickson1, Christopher V Dayas1.   

Abstract

The mechanistic target of rapamycin complex 1 (mTORC1) is necessary for synaptic plasticity, as it is critically involved in the translation of synaptic transmission-related proteins, such as Ca(2+)/Calmodulin-dependent kinase II alpha (CAMKIIα) and AMPA receptor subunits (GluAs). Although recent studies have implicated mTORC1 signaling in drug-motivated behavior, the ineffectiveness of rapamycin, an mTORC1 inhibitor, in suppressing cocaine self-administration has raised questions regarding the specific role of mTORC1 in drug-related behaviors. Here, we examined mTORC1's role in three drug-related behaviors: cocaine taking, withdrawal, and reinstatement of cocaine seeking, by measuring indices of mTORC1 activity and assessing the effect of intra-cerebroventricular rapamycin on these behaviors in rats. We found that withdrawal from cocaine self-administration increased indices of mTORC1 activity in the nucleus accumbens (NAC). Intra-cerebroventricular rapamycin attenuated progressive ratio (PR) break points and reduced phospho-p70 ribosomal S6 kinase, GluA1 AMPAR, and CAMKIIα levels in the NAC shell (NACsh) and core (NACc). In a subsequent study, we treated rats with intra-NACsh infusions of rapamycin (2.5 μg/side/day for 5 days) during cocaine self-administration and then tracked the expression of addiction-relevant behaviors through to withdrawal and extinction. Rapamycin reduced drug seeking in signaled non-drug-available periods, PR responding, and cue-induced reinstatement, with these effects linked to reduced mTORC1 activity, total CAMKIIα, and GluA1 AMPAR levels in the NACsh. Together, these data highlight a role for mTORC1 in the neural processes that control the expression and maintenance of drug reward, including protracted relapse vulnerability. These effects appear to involve a role for mTORC1 in the regulation of GluA1 AMPARs and CAMKIIα in the NACsh.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24469593      PMCID: PMC4023142          DOI: 10.1038/npp.2014.16

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  39 in total

1.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

Review 2.  The roles of calcium/calmodulin-dependent and Ras/mitogen-activated protein kinases in the development of psychostimulant-induced behavioral sensitization.

Authors:  Stephanie C Licata; R Christopher Pierce
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

3.  Propensity to 'relapse' following exposure to cocaine cues is associated with the recruitment of specific thalamic and epithalamic nuclei.

Authors:  M H James; J L Charnley; J R Flynn; D W Smith; C V Dayas
Journal:  Neuroscience       Date:  2011-09-28       Impact factor: 3.590

4.  Role for mammalian target of rapamycin complex 1 signaling in neuroadaptations underlying alcohol-related disorders.

Authors:  Jérémie Neasta; Sami Ben Hamida; Quinn Yowell; Sebastien Carnicella; Dorit Ron
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-01       Impact factor: 11.205

5.  Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking.

Authors:  Morgan H James; Janine L Charnley; Emily M Levi; Emma Jones; Jiann Wei Yeoh; Doug W Smith; Christopher V Dayas
Journal:  Int J Neuropsychopharmacol       Date:  2011-03-29       Impact factor: 5.176

6.  Transition to addiction is associated with a persistent impairment in synaptic plasticity.

Authors:  Fernando Kasanetz; Véronique Deroche-Gamonet; Nadège Berson; Eric Balado; Mathieu Lafourcade; Olivier Manzoni; Pier Vincenzo Piazza
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

7.  Rapamycin attenuates the expression of cocaine-induced place preference and behavioral sensitization.

Authors:  Jeffrey Bailey; Dzwokai Ma; Karen K Szumlinski
Journal:  Addict Biol       Date:  2011-03-11       Impact factor: 4.280

8.  Evidence for addiction-like behavior in the rat.

Authors:  Véronique Deroche-Gamonet; David Belin; Pier Vincenzo Piazza
Journal:  Science       Date:  2004-08-13       Impact factor: 47.728

9.  Effect of rapamycin on cue-induced drug craving in abstinent heroin addicts.

Authors:  Jie Shi; Wang Jun; Li-Yan Zhao; Yan-Xue Xue; Xiang-Yang Zhang; Thomas R Kosten; Lin Lu
Journal:  Eur J Pharmacol       Date:  2009-05-23       Impact factor: 4.432

10.  Differential control over cocaine-seeking behavior by nucleus accumbens core and shell.

Authors:  Rutsuko Ito; Trevor W Robbins; Barry J Everitt
Journal:  Nat Neurosci       Date:  2004-03-21       Impact factor: 24.884

View more
  11 in total

1.  Protein Translation in the Nucleus Accumbens Is Dysregulated during Cocaine Withdrawal and Required for Expression of Incubation of Cocaine Craving.

Authors:  Craig T Werner; Michael T Stefanik; Mike Milovanovic; Aaron Caccamise; Marina E Wolf
Journal:  J Neurosci       Date:  2018-02-05       Impact factor: 6.167

2.  VTA mTOR Signaling Regulates Dopamine Dynamics, Cocaine-Induced Synaptic Alterations, and Reward.

Authors:  Xiaojie Liu; Yan Li; Laikang Yu; Casey R Vickstrom; Qing-Song Liu
Journal:  Neuropsychopharmacology       Date:  2017-10-17       Impact factor: 7.853

3.  Ethanol Experience Enhances Glutamatergic Ventral Hippocampal Inputs to D1 Receptor-Expressing Medium Spiny Neurons in the Nucleus Accumbens Shell.

Authors:  Daniel M Kircher; Heather C Aziz; Regina A Mangieri; Richard A Morrisett
Journal:  J Neurosci       Date:  2019-01-28       Impact factor: 6.167

4.  Mammalian target of rapamycin complex 1 and its downstream effector collapsin response mediator protein-2 drive reinstatement of alcohol reward seeking.

Authors:  Sami Ben Hamida; Sophie Laguesse; Nadege Morisot; Jong-Hyun Park; Khanhky Phuamluong; Anthony L Berger; Ki Duk Park; Dorit Ron
Journal:  Addict Biol       Date:  2018-07-18       Impact factor: 4.280

Review 5.  Protein Translation and Psychiatric Disorders.

Authors:  Sophie Laguesse; Dorit Ron
Journal:  Neuroscientist       Date:  2019-07-04       Impact factor: 7.519

Review 6.  New directions in modelling dysregulated reward seeking for food and drugs.

Authors:  Robyn M Brown; Christopher V Dayas; Morgan H James; Rachel J Smith
Journal:  Neurosci Biobehav Rev       Date:  2021-11-02       Impact factor: 8.989

7.  Novelty preference does not predict trait cocaine behaviors in male rats.

Authors:  Shayna L O'Connor; Gary Aston-Jones; Morgan H James
Journal:  Addict Neurosci       Date:  2022-03-23

8.  PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.

Authors:  Karen K Szumlinski; Alexis W Ary; Christina B Shin; Melissa G Wroten; Justin Courson; Bailey W Miller; Micaela Ruppert-Majer; John W Hiller; John R Shahin; Osnat Ben-Shahar; Tod E Kippin
Journal:  Addict Biol       Date:  2018-11-18       Impact factor: 4.280

9.  The First Alcohol Drink Triggers mTORC1-Dependent Synaptic Plasticity in Nucleus Accumbens Dopamine D1 Receptor Neurons.

Authors:  Jacob T Beckley; Sophie Laguesse; Khanhky Phamluong; Nadege Morisot; Scott A Wegner; Dorit Ron
Journal:  J Neurosci       Date:  2016-01-20       Impact factor: 6.167

10.  Distinct miRNA expression in dorsal striatal subregions is associated with risk for addiction in rats.

Authors:  R K Quinn; A L Brown; B J Goldie; E M Levi; P W Dickson; D W Smith; M J Cairns; C V Dayas
Journal:  Transl Psychiatry       Date:  2015-02-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.